Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares stood at 78.22 million during the last session, with the company’s beta value hitting 2.06. At the close
In the last trading session, 190.59 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 1.81. With the company’s per
In last trading session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw 713.05 million shares changing hands with its beta currently measuring 1.97. Company’s recent per share
In recent trading session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw 51.47 million shares changing hands at last check today with its beta currently measuring 1.97.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.21 and has seen 1.15 billion shares traded in the last trading session. The company,
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.21 and has seen 41.68 million shares traded in the last trading session. The company,
During the recent session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares were 19.51 million, with the beta value of the company hitting 2.21. The 52-week
In the last trading session, 35.83 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) were traded, and its beta was 2.23. Most recently the
In the last trading session, 31.78 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) were traded, and its beta was 2.23. Most recently the
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares stood at 21.28 million during the last session, with the company’s beta value hitting 2.23. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
